Jacobs Levy Equity Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $429K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $34.4K | Sell |
|
|||||
|
2023
Q2 | $463K | Sell |
|
|||||
|
2023
Q1 | $738K | Sell |
|
|||||
|
2022
Q4 | $798K | Sell |
|
|||||
|
2022
Q3 | $1.18M | Sell |
|
|||||
|
2022
Q2 | $1.22M | Sell |
|
|||||
|
2022
Q1 | $1.37M | Sell |
|
|||||
|
2021
Q4 | $5.75M | Sell |
|
|||||
|
2021
Q3 | $8.34M | Sell |
|
|||||
|
2021
Q2 | $9.28M | Buy |
|
|||||
|
2021
Q1 | $9.42M | Buy |
|
|||||
|
2020
Q4 | $3.3M | Buy |
|
|||||
|
2020
Q3 | $724K | Buy |
|
|||||
|
2020
Q2 | $688K | Buy |
|
|||||
|
2020
Q1 | $86K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $221K | Buy |
|
|||||
|
2018
Q3 | $1.19M | Buy |
|
|||||
|
2018
Q2 | $1.01M | Buy |
|